


Healthcare News Roundup: LIcensing
HSMN NewsFeed - 21 Jan 2016
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
Halozyme Announces First Clinical Dosing Of Adalimumab (Humira) Using ENHANZE(TM) Technology
HSMN NewsFeed - 5 Jan 2016
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
